진학프로석·박사 채용 접수 플랫폼

A full-time Postdoctoral Fellow position (SKO 1352) is available for 3 years in the “Innate Lymphocyte Group” led by professor Marit Inngjerdingen at Department of Pharmacology, Institute of Clinical Medicine, University of Oslo. The position is funded through the Research Council of Norway (FIRPRO).

The Inngjerdingen lab focuses on NK cells, and how extracellular vesicles from NK cells can be exploited for cancer therapy against solid tumors. The group runs both basic science projects to uncover new mechanistic and biological insights, as well as innovation and commercialization projects.

The candidate will work on a project to develop extracellular vesicles (EVs) from NK cells as nanovehicles for cancer therapy. NK cells are exploited in immunotherapies against cancers. As NK cells have poor ability to infiltrate solid tumors, we are exploiting the possibility to utilize NK-cell derived extracellular vesicles (EVs) as a therapeutic product. The post doc project is focused on delineating the biogenesis of subsets of NK-EVs using state-of-the art molecular and cell biological tools, and understand how NK cells regulate their release. This work will be tied up with dissecting the functionality of different EV subsets. Methods include, but are not limited to, in vitro culture of primary human cells and cell lines, organ-on-chip models, molecular biology, diverse immunological assays, advanced flow cytometry, fluorescence microscopy, and CRISPR editing/screens.

For more information and how to apply: https://www.jobbnorge.no/en/available-jobs/job/281903/postdoctoral-fellow-position-in-biogenesis-of-extracellular-vesicles-from-nk-cells